To establish a National Center to Stop the Import of Illicit Synthetic Drugs.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill imposes short title This Act may be cited as the Stop the Import of Fentanyl Act of 2023 and provides national Center to Stop the Import of Illicit Synthetic Drugs There is within the Drug Enforcement Administration a National Center to Stop the Import of Illicit Synthetic Drugs (hereinafter referred to as. It relies on trade restrictions, definition changes, appropriations, and reporting requirements. The main policy areas are Healthcare Consumers, Healthcare, Agriculture, and Energy.
Who Benefits and How
Public beneficiaries or protected communities affected by the clause could face reduced risk.
Who Bears the Burden and How
Patients and health care consumers affected by the bill could lose revenue opportunities, Federal, state, or local agencies responsible for implementing the clause would take on compliance duties, and Foreign businesses and cross-border trade participants affected by the bill would take on compliance duties.
Key Provisions
- Imposes short title This Act may be cited as the Stop the Import of Fentanyl Act of 2023.
- Provides national Center to Stop the Import of Illicit Synthetic Drugs There is within the Drug Enforcement Administration a National Center to Stop the Import of Illicit Synthetic Drugs (hereinafter referred to as...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill imposes short title This Act may be cited as the Stop the Import of Fentanyl Act of 2023 and provides national Center to Stop the Import of Illicit Synthetic Drugs There is within the Drug Enforcement Administration a National Center to Stop the Import of Illicit Synthetic Drugs (hereinafter referred to as.
Key Policy Areas
Healthcare Consumers, Healthcare, Agriculture, Energy
Primary Purpose
The bill imposes short title This Act may be cited as the Stop the Import of Fentanyl Act of 2023 and provides national Center to Stop the Import of Illicit Synthetic Drugs There is within the Drug Enforcement Administration a National Center to Stop the Import of Illicit Synthetic Drugs (hereinafter referred to as.
Policy Domains
Whole bill
Identified Gains
- Public beneficiaries or protected communities affected by the clause
Identified Costs
- Patients and health care consumers affected by the bill
- Federal, state, or local agencies responsible for implementing the clause
- Foreign businesses and cross-border trade participants affected by the bill
- Environmental and public health interests affected by the bill
- Energy producers and energy supply-chain firms affected by the bill
Sponsors
Legislative Progress
IntroducedMs. Pettersen (for herself and Mrs. Beatty) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology